Lisdexamphetamine
| Vyvanse | |
|---|---|
| Salts [] | |
|---|---|
| Lisdexamphetamine didimesylate | |
| Lisdexamphetamine sulfate | |
| Molecular structure drawn from PubChem coordinates |
| Physical properties [] | |
|---|---|
| Molecular mass | 263.38 g/mol [1] |
| Appearance | Golden-colored solid from methanol [1] |
| Melting point | 191-193 [1] |
| Solubility | 792 mg/mL [1] |
| Predicted LogP | 1.2 [1] |
| Structural Identifiers [] | |
|---|---|
| Molecular formula | C15H25N3O |
| IUPAC name | (2S)-2,6-diamino-N-[(2S)-1-phenylpropan-2-yl]hexanamide |
| SMILES | C[C@@H](CC1=CC=CC=C1)NC(=O)[C@H](CCCCN)N |
| InChI | InChI=1S/C15H25N3O/c1-12(11-13-7-3-2-4-8-13)18-15(19)14(17)9-5-6-10-16/h2-4,7-8,12,14H,5-6,9-11,16-17H2,1H3,(H,18,19)/t12-,14-/m0/s1 |
| InChIKey | VOBHXZCDAVEXEY-JSGCOSHPSA-N |
| CAS number | 608137-32-2 |
| UNII | H645GUL8KJ |
| PubChem CID | 11597698 |
| Pharmacokinetics[] | |
|---|---|
| Onset | Oral: <2 hours[3][4] |
| Elimination half-life | Lisdexamfetamine: <1 hour, Dextroamphetamine: 10–12 h |
| Duration of action | 10–14 hours[5] |
| Metabolism | Hydrolysis by enzymes in red blood cells initially, subsequent metabolism follows |
| Excretion | Kidney: ~2% as Lisdexamfetamine and ~42% as Dextroamphetamine |
| Routes of administration | Oral |
| Dependence liability | Physical: None, Psychological: Moderate[6][7] |
| Addiction liability | Moderate |
Lisdexamphetamine (also known as L-lysine-d-amphetamine, lisdexanfetamina, L-lysine-dextroamphetamine, lisdexamfetaminum, (2S)-2,6-Diamino-N-((1S)-1-methyl-2-phenylethyl)hexanamide, (2S)-2,6-Diamino-N-[(1S)-1-methyl-2-phenylethyl]hexanamide, (2S)-2,6-diamino-N-((2S)-1-phenylpropan-2-yl)hexanimidic acid, (2S)-2,6-diamino-N-((2S)-1-phenylpropan-2-yl)hexanamide, (2S)-2,6-diamino-N-[(2S)-1-phenylpropan-2-yl]hexanimidic acid or N06ba12) is a codrug, prodrug and stimulant substance of the amphetamine class.
Chemistry
Salts []
Stereochemistry []
Lisdexamphetamine is a single defined stereoisomer.
Druglikeness
Lipinski's rule of five
Lisdexamphetamine matches Lipinski's rule of five.Reagents
There are currently 3 reagent-interactions on DrugsPRO
| Reagent | Color change | Description |
|---|---|---|
| Marquis | orange | |
| Mecke | no color change | |
| Mandelin | no color change |
Pharmacology
ATC Classification
- nervous system (N)
- psychoanaleptics (N06)
- psychostimulants, agents used for adhd and nootropics (N06B)
- centrally acting sympathomimetics (N06BA)
- lisdexamfetamine (N06BA12)
MeSH Classification
Mechanism of action []
Lisdexamfetamine is a prodrug of dextroamphetamine, which is a noncatecholamine sympathomimetic amine with CNS stimulant activity. Dextroamphetamine is a known inhibitor of the dopamine transporter (DAT), noradrenaline transporter (NET) and vesicular monoamine transporter 2 (VMAT2), with a weaker affinity for the serotonin transporter (SERT). It is also a weak monoamine oxidase (MAO) inhibitor. Dextroamphetamine ultimately blocks the reuptake of norepinephrine and dopamine into the presynaptic neuron and increases catecholamine availability in the extracellular space. The exact mode of therapeutic action of lisdexamfetamine in ADHD and BED has not been fully elucidated; however, the clinical effects of lisdexamfetamine are believed to be linked to the pharmacological actions of dextroamphetamine. [1]
Metabolism
Lisdexamphetamine acts as a codrug for:
| Metabolic pathways [] |
|---|
Interactions []
Medical side effects []
80 side effects listed on drug labels in SIDER 4.1 (lisdexamfetamine).
- Decreased appetite
- Anorexia
- Malnutrition
- Insomnia
- Mental disorder
- Gastrointestinal disorder
- Digestion impaired
- Abdominal pain upper
- Irritability
- Vomiting
- Weight decreased
- Nausea
- Anxiety
- Dry mouth
- Nervousness
- Feeling jittery
- Diarrhoea
- Hyperhidrosis
- Agitation
- Skin disorder
- Affect lability
- Blood pressure increased
- Dizziness
- Dyspnoea
- Body temperature increased
- Mediastinal disorder
- Nervous system disorder
- Dermatitis
- Rash
- Tachycardia
- Tremor
- Somnolence
- Aggression
- Anaphylactic shock
- Angioedema
- Bruxism
- Constipation
- Sudden death
- Depression
- Diplopia
- Dyskinesia
- Toxic epidermal necrolysis
- Eye disorder
- Asthenia
- Fatigue
- Hallucination
- Headache
- Cardiac disorder
- Hepatitis
- Hypersensitivity
- Immune system disorder
- Mydriasis
- Myocardial infarction
- Acute coronary syndrome
- Palpitations
- Convulsion
- Erythema multiforme
- Stevens-Johnson syndrome
- Cerebrovascular accident
- Tourette's disorder
- Urticaria
- Dyspepsia
- Dysphoria
- Euphoric mood
- Erectile dysfunction
- Hepatobiliary disease
- Psychotic disorder
- Mania
- Vision blurred
- Cardiomyopathy
- Dermatillomania
- Logorrhoea
- Libido decreased
- Disturbance in sexual arousal
- Hypertension
- Weight increased
- Ventricular hypertrophy
- Initial insomnia
- Middle insomnia
- Visual impairment
Indications
- Attention deficit disorder
- Attention deficit/hyperactivity disorder
- Forgetfulness
- Hyperkinesia
- Mental disorder
- Psychotic disorder
Subjective effects []
| 0xea / Lisdexamphetamine [] | |
|---|---|
Routes:
| |
| a1ko / Lisdexamphetamine [] | |
|---|---|
Routes:
| |
| alina / Lisdexamphetamine [] | |
|---|---|
Routes:
| |
| bonzi / Lisdexamphetamine [] | |
|---|---|
Routes:
| |
| emily / Lisdexamphetamine [] | |
|---|---|
Routes:
| |
| magnus / Lisdexamphetamine [] | |
|---|---|
Routes:
| |
| Mere / Lisdexamphetamine [] | |
|---|---|
| ninerik / Lisdexamphetamine [] | |
|---|---|
Routes:
| |
| Pilz / Lisdexamphetamine [] | |
|---|---|
Routes:
| |
Experience reports
- "I did 3 grams of mushrooms and it changed my life" by weezy-13 (36 upvotes)
- "Every Drug I've taken so far (AMA)" by Used-Philosopher-408 (26 upvotes)
- "First Shroom trip" by lavjah (23 upvotes)
- "First time doing DXM. (LONG)" by lolnoscopedtf (19 upvotes)
- "Weed + DPH + DXM + Codeine + Benzedrex + Hydroxyzine" by AdministrationMany53 (11 upvotes)
- "Possible Spice or Laced Weed Trip Report" by blackberry_55 (11 upvotes)
- "Meth Overdose: 36 Hours Tripping with Hellspawns" by echidnasarepinky (11 upvotes)
- "I got a little too high (and couldn’t form a sentence nor see anything, and thought I was going to die)." by 26LT (7 upvotes)
- "LSD trip 1000ug: Life Changing Ineffable Cosmic Beauty (60 hour trip)" by indianscammer69 (5 upvotes)
- "Xanman in space" by delsymchugger (5 upvotes)
- "Fuck Around And Find Out Nothing, or how I realized recreational amphetamine use was pointless for me" by Godless_Phoenix (4 upvotes)
- "Mind Blowing DOM Trip Report 2,5-Dimethoxy-4-methylamphetamine" by Lurendrejeriii (4 upvotes)
- "4.5g Psilocybin Trip Report" by ZeechSTi (2 upvotes)
- "2.5mg clonazepam (Benzodiazepines)" by azuraria (2 upvotes)
- "I popped two acid tabs and had the most meaningful sex of my life" by Gold_Performer6277 (1 upvotes)
- "First time on Vyvanse, took 200mg." by KeemoWolf (1 upvotes)
- "Currently on 450mg Vyvanse. An Update of sorts." by KeemoWolf (1 upvotes)
- "A Lackluster Venture In to Barb-Land" by Lysergedelia (1 upvotes)
- "340mg of Vyvanse / Trip report" by username_pickle (1 upvotes)
- "320mg vyvanse trip report" by username_pickle (1 upvotes)
- "vyvanse 350mg first time" by Jumpy_Revolution411 (1 upvotes)
- "How am I able to take such huge doses of drugs " by New-Perspective1594 (0 upvotes)
Legal status []
- Australia: Lisdexamphetamine is a Schedule 8.[8]
- Brazil: Lisdexamphetamine is a Class A3.[9]
- Germany: Lisdexamphetamine is a Anlage III under the "Betäubungsmittelgesetz (BtMG)".
- New Zealand: Lisdexamphetamine is a Class B.
- United Kingdom: Lisdexamphetamine is a Class B under the "Misuse of Drugs Act 1971".
- United States: Lisdexamphetamine is a Schedule II under the "Controlled Substances Act".[10]
- European Union: Lisdexamphetamine is Prescription only.[11]
- Other: Lisdexamphetamine is a SE: Förteckning II MX: Controlled / Rx-only.[12][13][14][15]
See also []
External links []
- Lisdexamphetamine (Wikipedia)
- Lisdexamphetamine (PubChem)
- Lisdexamphetamine (Wikidata)
- Lisdexamphetamine (DrugBank)
- Lisdexamphetamine (ChEMBL)
- Lisdexamphetamine (ChEBI)
- Lisdexamphetamine (Common Chemistry)
- Lisdexamphetamine (HMDB)
- Lisdexamphetamine (KEGG)
- Lisdexamphetamine (EPA DSSTox)
- Lisdexamphetamine (Effect Index)
- Lisdexamphetamine (UNII)
- Lisdexamphetamine (SIDER)
References []
National Center for Biotechnology Information. PubChem Compound Summary for CID 11597698, Lisdexamphetamine. Accessed November 20, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/11597698
U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Lisdexamphetamine. UNII: H645GUL8KJ. Global Substance Registration System. Accessed November 20, 2026. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/H645GUL8KJ
Millichap JG. Attention Deficit Hyperactivity Disorder Handbook: A Physician's Guide to ADHD. Springer. 2010.
Brams M, Mao AR, Doyle RL. Onset of efficacy of long-acting psychostimulants in pediatric attention-deficit/hyperactivity disorder. Postgraduate Medicine. September 2008; 120(3):69–88. PMID 18824827. https://doi.org/10.3810/pgm.2008.09.1909
Stahl SM. Prescriber's Guide: Stahl's Essential Psychopharmacology. Cambridge University Press. March 2017.
Adderall vs Vyvanse - What's the difference between them?. Drugs.com. https://www.drugs.com/medical-answers/adderall-vs-vyvanse-3013810/
Goodman DW. Lisdexamfetamine dimesylate (vyvanse), a prodrug stimulant for attention-deficit/hyperactivity disorder. P & T. May 2010; 35(5):273–287. PMID 20514273.
Australian Product Information Vyanse® (Lisdexamfetamine dimesilate). Department of Health and Aged Care. https://www.tga.gov.au/sites/default/files/auspar-lisdexamfetamine-dimesilate-180515-pi.pdf
RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial. Diário Oficial da União. 31 March 2023. https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-784-de-31-de-marco-de-2023-474904992
Vyvanse- lisdexamfetamine dimesylate capsule; Vyvanse- lisdexamfetamine dimesylate tablet, chewable. DailyMed. 10 March 2022. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=704e4378-ca83-445c-8b45-3cfa51c1ecad
List of nationally authorised medicinal products : Active substance(s): lisdexamfetamine : Procedure No. PSUSA/00010289/202002. Ema.europa.eu. https://www.ema.europa.eu/documents/psusa/lisdexamfetamine-list-nationally-authorised-medicinal-products-psusa/00010289/202002_en.pdf
Lisdexamfetamindimesilat. https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/substans/v2va9rlain4srv01/lisdexamfetamindimesilat
Elvanse (Kapsel, hård 30 mg) • Fass vy | FASS Vård. https://fass.se/health/product/20111213000092#:~:text=Om%20l%C3%A4kemedlet-,Narkotikaklass%20II,-S%C3%A4rskilt%20l%C3%A4kemedel
Anexo "Fracciones Arancelarias". Comisión Nacional de Mejora Regulatoria. https://www.cofemersimir.gob.mx/expediente/25222/mir/50628/anexo/5992654
Ley General de Salud. Cámara de Diputados del H. Congreso de la Unión. 15 January 2026. https://www.diputados.gob.mx/LeyesBiblio/pdf/LGS.pdf
Data sources []
| Source | Status | Updated (UTC) |
|---|---|---|
| dosing | missing (no dosing statistics) | 2026-11-20 09:59:30 |
| drugspro | ok | 2026-11-20 09:59:26 |
| erowid | missing (no Erowid substance of that name) | 2026-11-20 09:59:26 |
| gsrs | ok | 2026-11-20 09:59:26 |
| hmdb | missing (hmdb.ca refused automated access to HMDB0015385) | 2026-11-20 09:59:26 |
| kegg | ok | 2026-11-20 09:59:28 |
| pubchem | ok | 2026-11-20 09:59:26 |
| ok | 2026-11-20 09:59:26 | |
| sider | ok | 2026-11-20 09:59:26 |
| structure | ok | 2026-11-20 09:59:26 |
| wikipedia | ok | 2026-11-20 09:59:26 |